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Abstract. 
 
The 
 
a
 
-catenin molecule links E-cadherin/
 
b
 
-catenin or E-cadherin/plakoglobin complexes to the 
actin cytoskeleton. We studied several invasive human 
colon carcinoma cell lines lacking 
 
a
 
-catenin. They 
showed a solitary and rounded morphotype that corre-
lated with increased invasiveness. These round cell 
variants acquired a more normal epithelial phenotype 
upon transfection with an 
 
a
 
-catenin expression plas-
mid, but also upon treatment with the protein kinase C 
(PKC) activator 12-
 
O
 
-tetradecanoyl-phorbol-13-ace-
tate (TPA). Video registrations showed that the cells 
started to establish elaborated intercellular junctions 
within 30 min after addition of TPA. Interestingly, this 
normalizing TPA effect was not associated with 
 
a
 
-cate-
nin induction. Classical and confocal immunofluores-
cence showed only minor TPA-induced changes in 
E-cadherin staining. In contrast, desmosomal and tight 
junctional proteins were dramatically rearranged, with 
a conversion from cytoplasmic clusters to obvious con-
centration at cell–cell contacts and exposition at the ex-
terior cell surface. Electron microscopical observations 
revealed the TPA-induced appearance of typical des-
mosomal plaques. TPA-restored cell–cell adhesion was 
E-cadherin dependent as demonstrated by a blocking 
antibody in a cell aggregation assay. Addition of an an-
tibody against the extracellular part of desmoglein-2 
blocked the TPA effect, too. Remarkably, the combina-
tion of anti–E-cadherin and anti-desmoglein antibodies 
synergistically inhibited the TPA effect.
Our studies show that it is possible to bypass the need 
for normal 
 
a
 
-catenin expression to establish tight inter-
cellular adhesion by epithelial cells. Apparently, the 
underlying mechanism comprises upregulation of des-
mosomes and tight junctions by activation of the PKC 
signaling pathway, whereas E-cadherin remains essen-
tial for basic cell–cell adhesion, even in the absence of 
 
a
 
-catenin.
 
C
 
ell 
 
adhesion is essential for a wide variety of regu-
latory and developmental processes. The cad-
herins comprise a family of transmembrane, cell
 
surface glycoproteins that mediate Ca
 
2
 
1
 
-dependent cell–
cell adhesion (Takeichi, 1995). In cells with well developed
intercellular junctions, E-cadherin is concentrated in the
adherens junctions but appears to influence other intercel-
lular junctions such as gap junctions (Jongen et al., 1991;
Musil et al., 1990), tight junctions (Gumbiner et al., 1988;
Watabe et al., 1994), and desmosomes (Gumbiner et al.,
1988; Watabe et al., 1994; Amagai et al., 1995). E-cadherin
also plays a crucial role in development and maintenance
of cell polarity (Nelson, 1992; Eaton and Simons, 1995),
and its dysfunction has been strongly implicated in the in-
vasiveness and carcinogenesis of tumor cells and human
tumors (Vleminckx et al., 1991; Schipper et al., 1991; Berx
et al., 1995, 1996; Bracke et al., 1996).
Extracellularly, the individual cadherin molecules are
proposed to associate in a homophilic way to promote spe-
cific cell–cell interactions (Shapiro et al., 1995; Nagar et
al., 1996). Intracellularly, they interact with a group of pro-
teins, collectively termed catenins. 
 
a
 
-catenin has been pos-
tulated to link either cadherin/
 
b
 
-catenin or cadherin/pla-
koglobin complexes to F-actin, either directly or indirectly
via 
 
a
 
-actinin (Knudsen et al., 1995; Rimm et al., 1995). The
p120
 
cas
 
 protein associates also directly with the cytoplas-
mic domain of E-cadherin, but is not binding to 
 
a
 
-catenin
(Daniel and Reynolds, 1995). 
 
a
 
-catenin is divided into two
subtypes: 
 
a
 
E-catenin, which is expressed in many kinds of
tissues (Nagafuchi et al., 1991; Herrenknecht et al., 1991;
Nagafuchi and Tsukita, 1994), and 
 
a
 
N-catenin, expressed
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mainly in the nervous system (Hirano et al., 1992; Uchida
et al., 1994). For both subtypes two isoforms are known to
be expressed (Oda et al., 1993; Rimm et al., 1994).
In malignant cancers, inhibition of cell–cell adhesion is
indispensable as first step in the metastatic process. It has
been suggested that this detachment is related to reduced
expression of E-cadherin (van Roy and Mareel, 1992).
Moreover, it has been reported that in certain malignan-
cies, disruption of cell–cell adhesion was caused by re-
duced functionality of E-cadherin even though its expres-
sion level was normal (Bracke et al., 1996). Shimoyama et
al. (1992) reported an impairment of intercellular adhe-
sion in the lung cancer cell line PC-9, resulting from the
loss of expression of 
 
a
 
E-catenin. Using this cell line, re-
covery of E-cadherin function by transfection of 
 
a
 
N-cate-
nin or 
 
a
 
E-catenin cDNA was demonstrated (Hirano et al.,
1992; Watabe et al., 1994). A similar observation of im-
paired adhesion was made by Morton et al. (1993) for the
prostate cancer cell line PC-3 and ascribed to deletion of
 
a
 
-catenin genes. Vermeulen et al. (1995) showed that tran-
sition from the noninvasive to the invasive phenotype
might occur during culture of the human colon cell lines,
HCT-8 and DLD-1. This transition was associated with
loss of 
 
a
 
E-catenin expression. Furthermore, in particular
human cancer tissues immunohistological studies con-
firmed the loss of 
 
a
 
-catenin expression in vivo (Kadowaki
et al.,1994; Shiozaki et al., 1994). In the human gastric can-
cer cell line HSC-39, loss of E-cadherin–mediated intercel-
lular adhesion was explained by an in frame deletion of
the 
 
b
 
-catenin gene (Oyama et al., 1994; Kawanishi et al.,
1995). Also, tyrosine phosphorylation of catenins and cad-
herins down-modulates the function of the cadherin/cate-
nin system (Matsuyoshi et al., 1992; Behrens et al., 1993;
Hamaguchi et al., 1993; Empereur et al., 1997).
In addition, phosphorylation by protein kinase C (PKC)
 
1
 
represents a regulatory mechanism of intercellular adhe-
sion. The PKC protein family comprises several isoforms
of related serine/threonine-specific, phospholipid-depen-
dent kinases (Dekker et al., 1995). The phorbol ester 12-
 
O
 
-tetradecanoyl-phorbol-13-acetate (TPA) is a potent ac-
tivator of PKC. TPA has been shown to induce premature
compaction in the mouse embryo and a coincidental shift in
the localization of E-cadherin to the cell–cell contacts
(Winkel et al., 1990). A monoclonal antibody to E-cad-
herin as well as sphingosine, a potent PKC inhibitor, could
completely block this premature compaction.
In the present work, we analyzed the effect of the PKC
activator TPA on invasive 
 
a
 
-catenin–negative human co-
lon cell lines. The cell lines used are the HCT-8 derivatives
described before by Vermeulen et al. (1995). Our findings
reveal that it is possible to bypass by PKC activation the
need for 
 
a
 
-catenin to establish tight intercellular adhesion.
The underlying mechanism implicates a striking induction
of desmosomal junctions.
 
Materials and Methods
 
Cell Culture and Transfection
 
Human colon carcinoma cell lines were obtained and characterized as de-
 
scribed previously (Vermeulen et al., 1995). In brief, epithelioid variants
HCT-8/E8, HCT-8/E10, and HCT-8/E11 were obtained by subcloning the
HCT-8 cell line (ATCC CCL24; American Type Culture Collection,
Rockville, MD). In this and the following nomenclature, E stands for epi-
thelioid and substitutes for S, used before to indicate the smooth edges of
epithelial cell colonies. HCT-8/E11R1 (R, round cell variants) were ob-
tained by subcloning HCT-8/E11 cultures and selecting for a round cell
morphotype. HCT-8/R1 and DLD-1/R1 cell lines were obtained by sub-
cloning and selecting G418-resistant round cell variants from, respec-
tively, HCT-8 and DLD-1 (ATCC CCL221) cultures that were electropo-
rated with the pPNT vector, encoding a neo
 
r
 
 gene (Tybulewicz et al.,
1991). All cells were cultured in RPMI 1640 (GIBCO BRL, Ghent, Bel-
gium), supplemented with 10% FCS, 100 
 
m
 
g/ml streptomycin, and 250 IU/
ml penicillin. HCT-8 derivatives received 1 mM sodium pyruvate, whereas
2 mM 
 
l
 
-glutamine was added to DLD-1 derivatives. Cells were used be-
tween passage 5 and 30 after subcloning.
The expression vector of chicken 
 
a
 
N-catenin cDNA, pMiw-
 
a
 
N (Hirano
et al., 1992), was a generous gift from Dr. S. Hirano and Dr. M. Takeichi
(Kyoto University, Kyoto, Japan). HCT-8/E11R1 cells (4 
 
3
 
 10
 
6
 
 cells/75
cm
 
2
 
) were cotransfected by calcium phosphate coprecipitation with 20 
 
m
 
g
of linearized pMiw-
 
a
 
N plus 1 
 
m
 
g of linearized pSV2neo. The cells were re-
plated and cultured in the presence of 600 
 
m
 
g/ml of G418 to select stable
transfectants. Colonies of G418-resistant cells were isolated, tested by im-
munofluorescence for expression of 
 
a
 
N-catenin, and recloned if neces-
sary. Several stable clones were isolated.
 
Antibodies and Reagents
 
The following mouse monoclonal antibodies were used: antibodies
HECD-1 (Takara Biochemicals, Otsu, Japan) and MB2 (Bracke et al.,
1993) both functionally blocking human E-cadherin, 1G5 against 
 
a
 
-catenin
(Becton Dickinson, San Jose, CA), anti–
 
b
 
-catenin against 
 
b
 
-catenin
(Transduction Laboratories, Lexington, KY), anti-pp120 against p120
 
cas
 
(Transduction Laboratories), PG 5.1 against plakoglobin and DG 3.10
against desmoglein (both from Cymbus Bioscience Ltd., Southampton,
UK), 10G11 against desmoglein-2 (Progen, Heidelberg, Germany), DP
2.15 against desmoplakin I and II (Boehringer Mannheim, Mannheim,
Germany), hVIN-1 against vinculin (Sigma Immunochemicals, St. Louis,
MO), and htr-5 against the human TNF-receptor p55 (Brockhaus et al.,
1990). The rabbit polyclonal antibody pan-cadherin was obtained from
Sigma. The rat monoclonal MOC37 against human occludin and the
mouse monoclonal antibody against ZO-1 were kindly provided by, re-
spectively, Dr. M. Furuse (Furuse et al., 1994) and Dr. M. Itoh (Itoh et al.,
1991). The rat monoclonal antibody NCAT-2 against 
 
a
 
N-catenin and the
rat monoclonal antibody 
 
a
 
18 against 
 
a
 
-catenin were generous gifts of Dr.
S. Hirano and Dr. M. Takeichi (Hirano et al., 1992) and Dr. A. Nagafuchi
(Nagafuchi and Tsukita, 1994), respectively. Secondary and tertiary anti-
bodies coupled to biotin, FITC, or Texas red were obtained from Amer-
sham Life Science (Buckinghamshire, UK).
The concentration of 12-
 
O
 
-tetradecanoyl-phorbol-13-acetate (TPA;
Sigma) was 250 ng/ml, unless otherwise stated. A stock solution of TPA
was made at 250 
 
m
 
g/ml in DMSO. The final concentration of DMSO in
the culture medium was adjusted to 0.1%, and at this concentration the
solvent alone had minor or no effects on the cells. 1,2-dioctanoyl-
 
sn
 
-glyc-
erol (Sigma) was made up at a concentration of 50 mm in DMSO and used
at a final concentration of 0.5 mM.
 
Video Registration
 
To evaluate the effect of TPA on living cultures, time-lapse phase contrast
video registrations were made. Cells were placed on a Zeiss IM inverted
phase contrast microscope that was set up in a thermostabilized chamber
at 37
 
8
 
C, with continuous gassing with humidified air containing 5% CO
 
2
 
.
An F-LD 20/0.25 objective was used in combination with a long working
distance condensor (Zeiss No. 465224). Image capture was done via a high
resolution WV-1850C camera (National Panasonic, Tokyo, Japan) equipped
with an animation control unit AC-580 (EOS, Barry, UK), a time date
generator, and an impulse generator. For time-lapse films, two video im-
ages were recorded every 15 s. The video films were viewed at the normal
play-back speed of 25 images per second.
 
Ca
 
2
 
1
 
-dependent Fast Aggregation
 
Cell–cell adhesion was numerically evaluated in an aggregation assay as
described before (Bracke et al., 1993). In brief, cultures were dissociated
 
1. 
 
Abbreviations used in this paper
 
: PKC, protein kinase C; TPA, 12-
 
O
 
-
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into single cell suspensions under E-cadherin–saving conditions. They
were incubated under Gyrotory shaking at 80 rpm for 30 min in an iso-
tonic buffer containing either 1 mM EGTA or 1.25 mM Ca
 
2
 
1
 
. Treatment
of cells at 4
 
8
 
C with various antibodies was started 30 min before the aggre-
gation period and continued throughout incubation at 37
 
8
 
C. The aggrega-
tion index was expressed as 1-(N
 
30
 
/N
 
0
 
), where N
 
0
 
 indicates the initial num-
ber of particles and N
 
30
 
 the number of particles after 30 min of aggregation
as measured by a Coulter counter ZM (Coulter Electronics Ltd., Luton,
UK). All N
 
0
 
 and N
 
30
 
 measurements were done in duplicate and the exper-
iments were repeated at least twice. Cell aggregation was also measured
by use of an LS particle size analyzer (Coulter). Not the decreasing num-
ber of particles but the increasing size of particles was then used as an in-
dicative parameter for aggregation.
 
Metabolic Labeling and Immunoprecipitation
 
Cells were incubated for 3 h with [
 
35
 
S]methionine/cysteine (125 
 
m
 
Ci/ml,
Promix, SJQ 0079; Amersham Life Science) in methionine- and cysteine-
free MEM containing 5% dialyzed FCS. The cells were rinsed and ex-
tracted in a lysis buffer A, containing 0.5% NP-40, 6 mM CaCl
 
2
 
, 5 mM
MgCl
 
2
 
, 8 mM phenylmethylsulfonyl fluoride, 1 
 
m
 
M leupeptin, and 0.3 
 
m
 
M
aprotinin in PBS. Samples were diluted to contain equivalent trichloroacetic
acid-precipitable radioactivity, followed by preabsorption with protein-G
Sepharose 4 Fast Flow beads (Pharmacia, Uppsala, Sweden) for 1 h. Then,
the supernatant was incubated with 1 
 
m
 
g mAb for 3 h at 4
 
8
 
C. Subse-
quently, protein-G Sepharose 4 was added for one h. Adsorbed immuno-
precipitates were washed four times with lysis buffer and eluted with sam-
ple buffer (Laemmli, 1970). Protein separation was by 8% SDS-PAGE.
Radioactive signals were amplified by En
 
3
 
hance (Du Pont, Boston, MA)
before fluorography. Precipitated proteins were quantified with the aid of
a PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
In some experiments, cells were metabolically labeled for 3 h with
[
 
32
 
P]orthophosphate (PBS 13; Amersham Life Science) using 0.5 mCi/ml
in phosphate-free MEM. Cells were extracted in lysis buffer A, which con-
tained also the phosphatase inhibitors NaF at 10 mM and Na
 
3
 
VO
 
4
 
 at 1 mM.
 
Biotinylation of Cell Surface Proteins
 
Proteins at the exterior cell surface were specifically labeled by biotinyla-
tion with the membrane-impermeable reagent Sulfo-NHS-biotin (Pierce
Chemical Co., Rockford, IL) in PBS for 30 min at 4
 
8
 
C. Untreated cells
were compared with TPA-treated cells. After labeling, the monolayers
were washed four times with PBS and extracted with 0.5% NP-40, 0.5%
deoxycholate, 0.1% SDS, 8 mM phenylmethylsulfonyl fluoride, 1 
 
m
 
M leu-
peptin, and 0.3 
 
m
 
M aprotinin in PBS. Proteins (400 
 
m
 
g) were incubated
with 50 
 
m
 
l of 50% avidin-agarose (Pierce) for 18 h at 4
 
8
 
C to recover the bi-
otinylated proteins. The complexes were washed four times with lysis
buffer and proteins were eluted with sample buffer and resolved by 8%
SDS-PAGE. Proteins were detected by immunoblotting as described below.
 
Immunoblotting
 
Cells were dissolved in sample buffer (Laemmli, 1970) and boiled in the
presence of 5% 2-mercaptoethanol. Proteins were separated by 8% SDS-
PAGE, and transferred onto Immobilon-P membranes (Millipore Corp.,
Bedford, MA). After being blocked with 5% nonfat dry milk in PBS,
0.01% Tween-20, the membranes were incubated with the primary anti-
body. After extensive washing, the membranes were incubated with alka-
line phosphatase-conjugated antibodies using nitro blue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP) as substrate.
 
Cell Fractionation
 
Cells in 80-cm
 
2
 
 culture dishes were washed three times with PBS, col-
lected into a 1.5-ml microtube by scraping, and pelleted by mild centrifu-
gation. After removing the supernatant, 100 
 
m
 
l of 2.5% NP-40, 8 mM phe-
nylmethylsulfonyl fluoride, 1 
 
m
 
M leupeptin, and 0.3 
 
m
 
M aprotinin in PBS
was added to the cell pellet. Samples were incubated for 5 min with mild
pipetting, and then centrifuged at 22,000 
 
g
 
 for 15 min. Three-times con-
centrated sample buffer (Laemmli, 1970) was added to the supernatant, to
make a total volume of 150 
 
m
 
l, and used as the detergent soluble fraction.
On the other hand, the pellet fraction was dissolved in 100 
 
m
 
l of sample
Figure 1. TPA induces an epithelioid morphotype in round cell variants of colon cancer cells HCT-8. Epithelioid (HCT-8/E8, a and c)
and round cell variants (HCT-8/R1, b and d) were either untreated (a and b) or treated with 250 ng/ml TPA for 3 h (c and d). Similar ob-
servations were done for other round cell variants of HCT-8 and DLD-1. Bar, 20 mm. 
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buffer and used as the detergent insoluble fraction. Both fractions were
subjected to immunoblotting.
 
Immunofluorescence Microscopy
 
Monolayers prepared for fluorescent staining were grown on glass cover-
slips or on tissue culture-treated polycarbonate filters with a pore size of
0.4 
 
m
 
m (Transwell; Costar Corp., Cambridge, MA). Cell cultures were
treated with the appropriate agents, rinsed briefly with PBS, and fixed
with either ice-cold 100% methanol for 15 min at 
 
2
 
20
 
8
 
C or with 3%
paraformaldehyde in PBS for 20 min at room temperature. Fixation by
paraformaldehyde was followed by quenching in 50 mM NH
 
4
 
Cl solution in
PBS and by permeabilization in 0.2% (wt/vol) Triton X-100 in PBS for 5
min at room temperature. Then, cells were incubated for 1 h at 37
 
8
 
C with
primary antibody diluted in PBS, 0.04% gelatin. A washing step was fol-
lowed by the biotinylated secondary antibody under the same conditions
and then by Texas red–conjugated streptavidin for 30 min at 37
 
8
 
C. Finally,
cells were incubated in a 4
 
9-6-diamidino-2-phenylindole-solution and
mounted with Glycergel (Dako Corporation, Carpinteria, CA) or Vecta-
shield  (Vector Laboratories, Burlingame, CA) to prevent photobleaching.
Samples were examined with a Zeiss Axiophot photomicroscope or with a
Zeiss LSM 410 confocal laser-scanning immunofluorescence microscope
(Carl Zeiss, Jena, Germany).
Electron Microscopy
For the morphological analysis of ultrathin sections via EM, cells were
grown on Permanox plastic (Nunc, Roskilde, Denmark) and fixed with
2% glutaraldehyde in 100 mM cacodylate buffer (pH5 7.4) for 2 h. After
washing with plain buffer, samples were postfixed in 1% (wt/vol) OsO4 in
100 mM cacodylate buffer for 1 h. Samples were then dehydrated with a
graded series of ethanol and embedded in Epoxy Resin (ERL 4206;
Merck, Darmstadt, Germany). Ultrathin sections (50 nm) were cut with a
diamond knife, double stained with uranyl acetate and lead citrate, and
examined under an electron microscope (1200 EX II; Jeol, Tokyo, Japan)
at an accelerating voltage of 80 kV.
Results
Characterization of Round Cell Variants of Human 
Cancer Cells
Round cell (R) variants, e.g., HCT-8/R1, HCT-8/E11R1,
DLD-1/R1, seemed to emerge in a spontaneous way from
the human colon cancer cell lines HCT-8 and DLD-1
(Vermeulen et al., 1995). In contrast to the epithelioid sub-
clones (Fig. 1 a), R-variants grew as loosely adherent clus-
ters of cells, including spherical halo-forming cells on top
of confluent parts of the monolayer (Fig. 1 b). At the pro-
tein level, the R-variants were found to be negative for
a-catenin as revealed by Western blotting and coimmuno-
precipitation experiments (Fig. 2, a and b; Vermeulen et
al., 1995). Nevertheless, they contained both E-cadherin
and b-catenin in a macromolecular complex containing
additional proteins too (Fig. 2 b). E-cadherin–mediated
cell–cell adhesion of R-variants was strongly reduced, as
demonstrated in the Ca21-dependent fast aggregation as-
say (Fig. 3; Vermeulen et al., 1995). Dysfunction of the
E-cadherin/catenin complex was also demonstrated by
formation of loose colonies inside collagen and by inva-
sion into organ cultures, whereas the epithelioid E-vari-
ants formed tight colonies inside collagen and were nonin-
vasive (Vermeulen et al., 1995). In the following experiments,
we used the HCT-8/E8 and HCT-8/R1 cell lines as proto-
types of variants with, respectively, the epithelioid (E) and
round (R) morphotype. Several other isolated S- and R-clones
(see Materials and Methods) behaved essentially in the
same way.
TPA Treatment Restores Cell–Cell Adhesion
of R-variants
Interestingly, addition of TPA (250 ng/ml) to adherent col-
onies of R-variants of HCT-8 or DLD-1 caused striking al-
terations in cell morphology. By time-lapse video registra-
tion, nonconfluent monolayers of cells were followed
before and during 4 h of TPA treatment. The first changes
were apparent within 30 min. The treated cells adopted
progressively a typical polygonal epithelioid morphology
(illustrated for HCT-8/R1 in Fig. 1 d). Besides this remark-
able change in R-variants, TPA showed additional effects
that were similar for both epithelial and round cell vari-
ants. Cell ruffling activity increased very much as well as
cell spreading on the surface in the case of subconfluent
cultures (Fig. 1, c and d; video registration data not shown).
In line with the TPA-induced morphological changes in
R-variants, we noticed in a cell–cell aggregation assay that,
upon treatment with increasing doses of the phorbol ester
TPA, the deficient aggregation of R-variant cell suspen-
Figure 2. Round cell variants of HCT-8 lack a-catenin in the
E-cadherin/catenin complex. (a) Western blotting for a- and b-cat-
enin in total lysates of the epithelioid variant HCT-8/E8 and the
round cell variant HCT-8/R1. Cells were treated with TPA for the
time periods indicated. (b) Metabolically labeled cell extracts of
the epithelioid variant HCT-8/E10 (E) and of the round cell vari-
ant HCT-8/R1 (R) were subjected to immunoprecipitation with
(left two lanes) or without (right two lanes) E-cadherin–specific
mAb HECD-1. Positions of E-cadherin (E-cadh) and catenins
(ctn) are indicated by arrows. Molecular mass markers are indi-
cated on the right. In cell line HCT-8/E10, E-cadherin was associ-
ated with a-, b-, and g-catenin (left lane). The round cell variant
HCT-8/R1 lacked a-catenin in the complex (second lane).van Hengel et al. PKC Induces Desmosomes in a-Catenin–negative Cells 1107
Figure 4. Cell–cell adhesion via E-cadherin and
desmoglein-2 occurs by a cooperative mecha-
nism in both E-variants and TPA-treated R-vari-
ants. Monolayers of HCT-8/R1 cells (R) were
treated with 250 ng/ml TPA as indicated in Ma-
terials and Methods. Monolayers of HCT-8/E8
cells (E) were not treated with TPA here (b and
d), although analysis of TPA-treated E-variants
yielded essentially identical data (not shown).
Both R- and E-variants were analyzed for cell
aggregation (increasing particle volume) either
after 0 min (broken lines in a and b; peak posi-
tions indicated by 0-min arrows in c and d) or af-
ter 30 min of incubation at 378C (full lines in all
panels). Aggregation for 30 min by R-variants,
which were not treated with TPA, yielded curves
coinciding with the 0-min curves (not shown).
Other curves depicted correspond with the fol-
lowing antibody treatments (see also Materials
and Methods). The mAb MB-2 against human
E-cadherin (O) was used at an effective concen-
tration (dilution 1:20; a and b), or at a more inef-
fective concentration (1:200; c and d, with in c
only peak position indicated by an arrow). The
mAb 10G11 against desmoglein-2 (h) was also
used at an effective concentration (1:2; a and b),
or at an ineffective concentration (1:8; c and d,
with in d only peak position indicated by an ar-
row). These two antibodies, both at the lower
concentrations, were also combined as indicated
by filled circles (d) in c and d. Upon such combi-
nation, a clear-cut synergistic inhibition of cell
aggregation was observed for both cell types.
Figure 3. TPA induces cell aggregation in a-catenin–negative
variants of HCT-8. Monolayer cultures of the epithelioid HCT-8/
E10 cell line and of the a-catenin–negative variant HCT-8/R1
were pretreated for 3 h with the indicated amounts of TPA.
Then, cells were dissociated under E-cadherin saving conditions
and allowed to reaggregate from single cell suspensions for 30
min at 378C in the presence of the same TPA concentrations. The
sions could be progressively normalized to the aggregation
level of the epithelioid E-variants (Fig. 3). Three indepen-
dently obtained round cell populations, HCT-8/R1, HCT8/
E11R1, and DLD-1/R1, responded in the same way. This
restoration was evident as soon as 30 min after application
of 100 ng/ml TPA (data not shown). In most subsequent
experiments TPA was used at 250 ng/ml. The restored in-
tercellular adhesion was Ca21- and E-cadherin–dependent
since it could be prevented by adding, together with TPA,
either EGTA (data not shown), or the E-cadherin block-
ing monoclonal antibody MB2 (open circles in Fig. 4 a).
These features resemble the Ca21- and E-cadherin–depen-
dent adhesion observed in the E-variants in the absence of
TPA (as shown for HCT-8/E8 in Fig. 4 b). TPA (>30 ng/
ml) increased also to some extent the cell–cell aggregation
of the E-variants HCT-8/E8 (not shown) and HCT-8/E10
(Fig. 3). TPA-induced intercellular adhesion was transient
for both cell types, as might be expected for a PKC activa-
tion process (Hecht et al., 1994). By 6 h after starting the
TPA treatment, cell–cell adhesion was abolished again
(data not shown). Finally, 1,2-dioctanoyl-sn-glycerol, a
synthetic analogue of diacyl glycerol, showed at 0.5 mM
similar effects to those of 250 ng/ml TPA in HCT-8/R1
cells (not shown).
degree of cell aggregation (decreased particle number) was calcu-
lated using the formula 1-N30/N0. Similar observations were done
for other round cell variants of HCT-8 and DLD-1.The Journal of Cell Biology, Volume 137, 1997 1108
TPA Effects on the E-Cadherin/Catenin Complex
of R-variants
TPA induction of cell–cell adhesion by a-catenin–negative
tumor cells may occur via upregulation of the E-cadherin
function. Therefore, the molecular elements of the E-cad-
herin/catenin complex were studied by immunoblotting,
immunohistochemistry, and coimmunoprecipitation. HCT-8
cells have an epithelial origin and express E-cadherin as
expected. Another classical cadherin was not present as
demonstrated by immunoblotting with a pan-cadherin an-
tibody (results not shown). The simplest explanation for
the observed phenomenon is that TPA induces a-catenin
expression. This was assessed by Western blotting with
two different mAb recognizing, respectively, the NH2-ter-
minal and middle part of aE-catenin. TPA did not at all
induce a-catenin expression in HCT-8/R1 cells and also
the level of b-catenin expression was not influenced by
TPA treatment (Fig. 2 a; plus data not shown).
For immunohistochemistry, cells were treated by TPA
for increasing time periods, fixed, and stained with anti-
bodies against E-cadherin, b-catenin, and p120cas proteins.
Both classical and confocal immunofluorescence was ap-
plied. In untreated E- and R-variants, these three proteins
were distributed predominantly at plasma membrane sites
involved in lateral cell–cell contacts (illustrated for E-cad-
herin in Fig. 5, a and b). The spherical cells on top of
monolayers of R-variants especially expressed E-cadherin
on their whole surface (Fig. 5 b). Treatment with TPA for
3 h emphasized the honeycomb pattern of E-cadherin
staining, particularly in R-variants, but there was no evi-
dence for redistribution of E-cadherin, b-catenin, or p120cas
into restricted positions (adherens junctions) at the lateral
cell–cell contacts (Fig. 5 c, and data not shown).
We next addressed the question whether vinculin, which
shows sequence similarities to a-catenin (Herrenknecht et
al., 1991), would replace a-catenin in the E-cadherin/cate-
nin complex of TPA-treated R-variants. In the untreated
cells, vinculin is found at the level of the substratum con-
tacts. TPA treatment partly redistributed the vinculin to a
diffuse cytoplasmic staining but not at all to cell–cell contacts
(data not shown). Moreover, coimmunoprecipitation experi-
ments did not show any change in the E-cadherin/catenin
complex upon TPA treatment. The same pattern was seen as
depicted in Fig. 2 b, and neither a-catenin nor another pro-
tein like vinculin seemed to be induced by TPA in the com-
plex (Fig. 2 a; and data not shown). This was also obvious
Figure 5. No major effect on E-cadherin, but formation of typical tight junctions and spot desmosomes upon TPA treatment of
a-catenin–negative variants of HCT-8. Cells were double stained for E-cadherin (a–c) and occludin (d–f), or stained for desmoglein-2
(g–i). Each panel comprises an extended depth view by overlaying several confocal X-Y sections (top) and confocal X-Z sections of the
same field (bottom). Cells analyzed were: epithelioid HCT-8/E8 cells (a, d, g), untreated HCT-8/R1 cells (b, e, h), and TPA-treated (250
ng/ml for 3 h) HCT-8/R1 cells (c, f, i). Bar, 14 mm.van Hengel et al. PKC Induces Desmosomes in a-Catenin–negative Cells 1109
from analysis of phosphorylated proteins in the E-cadherin/
catenin complex after TPA treatment (data not shown).
Immunostaining for plakoglobin (g-catenin) revealed a
honeycomb pattern in the epithelioid HCT-8/E8 cells (Fig.
6 a). In contrast, plakoglobin was located in small granular
dots in the cytoplasm of R-variants and was rarely detect-
able at sites of cell–cell contact (Fig. 6 b). TPA treatment
for 30 min induced formation of bigger dots and after a 3-h
treatment a honeycomb pattern appeared with continu-
ously stained lines at cell–cell contacts (Fig. 6 c). In conclu-
sion, several components of the cadherin/catenin complex
were originally present at the cell surface of R-variants, ex-
cept for plakoglobin and a-catenin. Plakoglobin was induced
to relocalize to the cell–cell contacts upon TPA treatment,
whereas a-catenin expression remained totally defective.
TPA Reorganizes Desmosomal and Tight Junctional 
Proteins in R-variants
Plakoglobin is the only protein within the E-cadherin/cate-
Figure 6. Relocalization of desmosomal proteins to cell–cell contacts upon TPA treatment of a-catenin–negative variants of HCT-8.
Cells were stained for plakoglobin (a, b, and c), desmoglein-2 (d, e, and f), or desmoplakin (g, h, and i). In the untreated epithelioid vari-
ant HCT-8/E8, desmosomal proteins were localized at the cell–cell contacts (a, d, and g). HCT-8/R1 cultures were either untreated (b, e,
and h) or treated for 3 h with 250 ng/ml TPA (c, f, and i). Similar observations were done for other R-variants of HCT-8. Bar, 10 mm.The Journal of Cell Biology, Volume 137, 1997 1110
nin complexes that is known to localize also in spot desmo-
somes. Colon carcinoma cell lines express the desmoglein-2
isoforms (Schmidt et al., 1994). This was confirmed also
for HCT-8 and DLD-1 cells by a desmoglein-2 specific an-
tibody. In the epithelioid variants, both desmoglein-2 and
desmoplakin proteins were detectable as punctuated lines
along the cell outlines (Figs. 5 g; 6, d and g). In the R-vari-
ants, desmoglein-2 and desmoplakin proteins were present
as granular dots in the cytoplasm nearby the plasma mem-
brane and at rare points of cell–cell contacts (Figs. 5 h; 6, e
and h). An increase in the intensity and number of des-
moglein-2 and desmoplakin-containing fluorescent spots
throughout the cytoplasm was induced by 30 min of TPA
treatment (not shown). This may be the result of antigen
clustering. Longer treatment resulted in clearing of the in-
tracellular staining with concomitant increase in staining
at the plasma membrane. By 4 h of TPA treatment, the
punctuated peripheral staining characteristic of desmo-
somes was apparent and about no intracellular staining re-
mained (Figs. 5 i; 6, f and i).
Besides desmosomal proteins, also the tight junctional
proteins ZO-1 and occludin relocalized to the membrane
upon TPA treatment of R-variants. In the epithelioid
HCT-8/E8 cells, ZO-1, and occludin-specific immunoreac-
tivities were situated at the expected location of tight junc-
tions, i.e., at the apical ends of lateral cell–cell contacts and
extending over the whole cell perimeter (Figs. 5 d; 7, a and
d). ZO-1 and occludin were apparently clumped together
nearby or at cell–cell contacts of untreated R-variants
(Figs. 5 e; 7, b and e), but they reorganized dramatically to
the typical tight junction line pattern upon TPA treatment
(Figs. 5 f; 7, c and f). Nevertheless, some discontinuities re-
mained even after 4 h of TPA treatment, and transepithe-
lial electrical resistance was not built up (the latter data
not shown).
We performed an ultrastructural analysis to determine
whether our immunofluorescence data represented the
TPA-induced assembly of genuine cell junctions in R-vari-
ants. E-variants exhibited many well developed intercellu-
lar junctions and showed interdigitation of juxtaposed
plasma membranes (Fig. 8 a). Moreover, these cells pos-
sessed short microvilli (not shown). In contrast, untreated
R-variants revealed no detectable adhesion specializations
along the whole length of their non-interdigitated cell–cell
contact surfaces (Fig. 8, b and d). The TPA-treated R-vari-
ants, however, demonstrated an evident array of junctions,
including tight junction–like structures and classical des-
mosomes with attached intermediate filaments (Fig. 8, c
and e).
TPA-induced Cell Aggregation Is
Desmosome Dependent
Next, we wondered whether desmosomal cadherins were
causally involved in restoration of TPA-induced cell–cell
adhesion of the a-catenin–negative R-variants. Addition
Figure 7. Relocalization of tight junctional proteins to cell–cell contacts upon TPA treatment of a-catenin–negative variants of HCT-8.
Double immunofluorescence was performed for ZO-1 (a–c) and occludin (d–f). In the untreated epithelioid variant HCT-8/E8, the ZO-1
and occludin proteins were localized at the apical side of lateral cell–cell contacts (a and d). ZO-1 and occludin colocalized in a granular,
dot-like pattern in untreated HCT-8/R1 cells (b and e), but after treatment for 3 h with 250 ng/ml TPA, they became largely concen-
trated at sites of cell–cell contact (c and f). Bar, 10 mm.van Hengel et al. PKC Induces Desmosomes in a-Catenin–negative Cells 1111
of antibody 10G11, directed against the extracellular part
of desmoglein-2, blocked indeed the TPA-induced cell ag-
gregation (open squares in Fig. 4 a). This inhibition was
antibody concentration dependent (not shown). The mAb
htr5 against TNF-receptor p55 is of the same IgG isotype
as 10G11, but showed no effect on TPA-induced aggrega-
tion (not shown). This result was clearly reminiscent of the
above mentioned anti–E-cadherin antibody effect (open
circles in Fig. 4 a). This double E-cadherin–plus desmo-
glein-2 dependence was also noticed for E-variants, al-
though antibodies against desmoglein-2 were less inhibi-
tory than anti–E-cadherin antibodies (Fig. 4 b). In E-cells,
the E-cadherin–mediated cell–cell adhesion is apparently
more important, or the desmoglein-2 molecules are less
accessible to blocking antibodies. In agreement with this,
the anti–desmoglein-2 antibody used here was originally
described to be nonblocking in epithelial cell monolayers
(Demlehner et al., 1995), and this was essentially con-
firmed by us.
To investigate in more detail the observed antibody ef-
fects, a noneffective anti–E-cadherin antibody concentra-
tion was combined with a noneffective anti–desmoglein-2
antibody concentration. It is interesting that this resulted
in a synergistically enhanced inhibition of cell–cell adhe-
sion, both in TPA-treated R-variants (filled circles in Fig.
4 c) and in E-variants with or without TPA (partly shown
in Fig. 4 d).
Antigen Exposition at the Cell Surface Antigens and 
Detergent Solubility
To further verify the presence of E-cadherin and desmo-
glein-2 at the outer side of the plasma membrane, we se-
lectively biotinylated the cell surface of TPA-treated E- and
Figure 8. Upon TPA treat-
ment,  a-catenin–negative
cells start to exhibit various
cell junctions as demon-
strated by electron micros-
copy. Untreated HCT-8/E8
cells (a) show tight-junction-
like structures (small arrows),
desmosomes (large arrows),
and membrane interdigita-
tions (arrowhead) at lateral
cell–cell contacts. All these
features are consistently
lacking in untreated HCT-8/
R1 cells (b and d). In con-
trast, TPA-treated HCT-8/
R1 cells (c and e) form mor-
phologically typical tight
junctions (small arrows) and
desmosomes (large arrows).
The latter are clearly linked
to 10-nm intermediate fila-
ments (e). A, apical side of
the cells. Bars: (a–c) 280 nm;
(d and e) 120 nm.The Journal of Cell Biology, Volume 137, 1997 1112
R-variants with a membrane-impermeable reagent, sulfo-
NHS-biotin. Biotinylated proteins were recovered with
immobilized avidin and subjected to immunoblotting with
antibodies against E-cadherin or desmoglein-2 (Fig. 9).
E-cadherin was expressed at the plasma membrane of
both cell types, HCT-8/E8 and HCT-8/R1, and TPA treat-
ment had no obvious influence on the extent of biotinyla-
tion of E-cadherin. Upon prolonged exposure to TPA, the
intensity decreased slightly, probably due to downregula-
tion of PKC (Winkel et al., 1990; Hecht et al., 1994). Des-
moglein-2 was detectable at the plasma membrane of the
epithelioid HCT-8/E8 cells and a 1-h treatment with TPA
increased to some extent the biotinylation of desmoglein-2.
In clear contrast to E-variants, no desmoglein-2 could be
biotinylated in the plasma membrane of the untreated
R-variants. However, TPA treatment of the R-cells in-
creased desmoglein-2 biotinylation progressively (Fig. 9).
These results show that E-cadherin is exposed at the
plasma membrane of the a-catenin–negative R-variants
and that desmoglein-2 appears at the cell surface solely
upon TPA treatment. These findings consolidate the re-
sults obtained by immunohistochemistry and EM.
Nevertheless, in cell fractionation experiments the bulk
of desmoglein-2 molecules was recovered in the detergent
insoluble fraction and this was found for both E- and
R-variants, irrespective of TPA treatment (Fig. 10). This
points at a cytoskeleton linkage of desmoglein-2 molecules,
even if not exposed at the cell surface of untreated R-cells.
E-cadherin,  b-catenin, and plakoglobin molecules were
detected in both insoluble and soluble fractions under our
fractionating conditions and TPA treatment did not in-
duce any obvious changes (Fig. 10).
Transfection of the Round Cell Variants with
aN-Catenin cDNA
Finally, we examined whether a-catenin cDNA expression
could restore the deficient cell adhesion and induce des-
mosome formation in the R-variants. HCT-8/E11R1 cells
were transfected with a G418-resistance plasmid in combi-
nation with pMiw-aN, encoding chicken aN-catenin (Hirano
et al., 1992). Colonies with stable expression of this ectopic
aN-catenin were selected by Western blotting using mAb
NCAT-2, specific for aN-catenin (Fig. 11; Hirano et al.,
1992). From immunohistochemistry, it turned out that it was
difficult to obtain a stable homogeneous aN-catenin posi-
tive cell population. The cloned transfectants HRpCaN1
and HRpCaN2 were further studied because of more con-
sistent expression of aN-catenin in an epithelial honey-
comb pattern at the cell–cell contacts (Figs. 11 and 12 a;
Table I). No a-catenin expression was detected in trans-
fectant HRpCaN3 (Fig. 11 and Table I), and this served as
a negative control in our experiments. Immunohistochem-
istry of transfectants HRpCaN1 and HRpCaN2 revealed
a honeycomb staining for aN-catenin, E-cadherin, b-cate-
nin, p120cas, and also the proteins of spot desmosomes and
tight junctions (illustrated for desmoglein-2 in Fig. 12 b).
Restoration of the intact E-cadherin/catenin complex in
the HRpCaN1 and HRpCaN2 transfectants was con-
firmed also by immunoprecipitation (data not shown), and
the functionality of this complex was demonstrated in a
fast aggregation assay (Table I).
Discussion
It is generally accepted that in assembling epithelia, sur-
face interactions between adhesion molecules of the cad-
herin superfamily are the starting point of the molecular
cascade that leads to the formation of other junctions like
desmosomes and tight junctions (Lewis et al., 1994; Ama-
gai et al., 1995; Gumbiner, 1996). The possibility of cad-
herin-mediated cell–cell adhesion in the absence of a-cate-
nin, as obtained in this study upon TPA treatment of
R-variants, seems to contradict this. Many studies (Ozawa
et al., 1990; Hirano et al., 1992; Shimoyama et al., 1992;
Breen et al., 1993; Morton et al., 1993; Watabe et al., 1994;
Ewing et al., 1995; Rimm et al., 1995) have led to the gen-
erally accepted principle of cadherin function: cadherins
must bind catenins inside the cell for them to function
properly outside the cell. This molecular complex is thought
to confer adhesive strength because catenins link the cad-
herins to the actin cytoskeleton and because clustering of
the cadherin molecules should increase the avidity of their
Figure 9. TPA induces exposition of desmoglein-2 molecules at
the cell surface in a-catenin–negative variants of HCT-8. Mono-
layers of the epithelioid HCT-8/E8 (E) and of the round cell vari-
ant HCT-8/R1 (R) were treated for the indicated times with 250
ng/ml TPA, and then labeled with NHS-biotin for 30 min and ex-
tracted with lysis buffer. Biotinylated proteins were purified by
adsorbing to avidin-agarose beads and analyzed by Western blot-
ting using antibodies to E-cadherin (HECD-1) or desmoglein
(DG 3.10).
Figure 10. TPA does not modify the detergent solubility of E-cad-
herin, b-catenin, plakoglobin, and desmoglein-2. Monolayers of
HCT-8/E8 (E) and HCT-8/R1 (R) were either untreated or
treated with 250 ng/ml TPA for 3 h as indicated. Detergent (2.5%
NP-40) soluble and insoluble fractions were prepared and ana-
lyzed by Western blotting using antibodies to the antigens indi-
cated at the right.van Hengel et al. PKC Induces Desmosomes in a-Catenin–negative Cells 1113
interactions. However, in spite of this model, evidence ex-
ists that in special situations the extracellular part of cad-
herins might retain some biological activity in the absence
of catenin linkage. A chimeric molecule consisting of the
extracellular part of E-cadherin and the transmembrane
and intracellular part of N-CAM is able to function in ad-
hesion (Jaffe et al., 1990). Likewise, the intracellular do-
main of desmoglein-3 confers adhesive functionality on
the extracellular domain of E-cadherin (Roh and Stanley,
1995). Both types of chimeric molecules do not use a-cate-
nin to mediate their adhesive function. Also, T-cadherin,
which is anchored to the membrane by a glycosyl phos-
phatidylinositol group instead of a transmembrane do-
main, does not interact with catenins, but it can still medi-
ate cell–cell adhesion to some extent (Vestal and Ranscht,
1992). On the other hand, an E-cadherin–a-catenin fusion
molecule confers a strong and inflexible adhesive pheno-
type upon cells (Nagafuchi et al., 1994). The latter finding
emphasizes, besides a putative modulating role of b-cate-
nin, the importance of the a-catenin–cytoskeleton connec-
tion for tight cell adhesiveness.
Our antibody inhibition experiments show that E-cad-
herin plays an essential role in the TPA-induced cell ag-
gregation by R-variants, despite the sustained absence of
any a-catenin expression. In line with this, E-cadherin–
defective cells such as Colo320DM did not show this TPA-
induced cell aggregation (our data not shown). From coim-
munoprecipitation, immunofluorescence, and cell surface
biotinylation experiments, we could conclude that E-cad-
herin molecules are expressed at the cell surface of a-cate-
nin–negative R-variants. They form a complex with b-cate-
nin and with part of the intracellular plakoglobin and
p120cas molecules. R-variants expressed E-cadherin, b-cate-
nin, and p120cas also at free cell borders besides cell–cell
contacts, whereas plakoglobin was largely stained as cyto-
plasmic clumps. Upon TPA treatment of R-variants, cad-
herin–catenin complexes did not translocate completely to
cell–cell contacts, contrary to what might be expected for a
functional cadherin–catenin complex. We tried to clarify
this phenomenon by determining the detergent soluble
and insoluble fractions of the cells. In accordance with a
Figure 11. Expression of aE- and aN-catenin in HCT-8 variants
and transfected derivatives. Expression levels were assessed by
Western blotting using anti-aE-catenin mAb 1G5 and anti-aN-
catenin mAb NCAT-2. Total cell lysates of epithelioid HCT-8/E8
cells contained aE-catenin, whereas the round cell variant HCT-
8/E11R1 expressed neither aE- nor aN-catenin. The transfected
clones HRpCaN1 and HRpCaN2 expressed the exogenous aN-
catenin cDNA. Transfectant HRpCaN3 expressed no detectable
a-catenins and served as a negative control in further experi-
ments.
Figure 12. Transfection of aN-catenin cDNA into the round cell variant HCT-8/E11R1 induces desmosome formation. Transfected cell
clone HRpCaN2 was fixed and double stained with anti-aN-catenin mAb (a) and anti-desmoglein mAb (b). Note the different location
of the two antigens, with the immunoreactivity of desmoglein being punctate as might be expected for typical desmosomes. Bar, 5 mm.
Table I. Effects of Exogenous a-Catenin Expression by Round 
Cell Variants on Cell Aggregation
Fast aggregation assay
Cells* Western blot‡ Immunostaining‡ 1-(N30/N0)
HCT-8/E8 11 0.6
HCT-8/E11R1 22 0.0
HRpCaN1 11 0.5
HRpCaN2 11 0.5
HRpCaN3 22 0.1
*The epithelial HCT-8/E8 cells express endogenous aE-catenin and serve as a posi-
tive control.
‡1, positive for aE-catenin in the case of HCT-8/E11R1, and positive for aN-catenin
in the case of HRpCaN clones (see Figs. 11 and 12); 2, negative for both aE- and
aN-catenin.The Journal of Cell Biology, Volume 137, 1997 1114
report on a-catenin–negative PC-9 cells (Shimoyama et
al., 1992), our data suggest that a-catenin–lacking E-cad-
herin complexes are still associated in some way with de-
tergent insoluble material. Moreover, the striking effect of
TPA on cell adhesion by R-variants was apparently not
due to strengthened association of E-cadherin with, e.g., the
cytoskeleton. Another possible level of cell adhesion regu-
lation is via modulation of b-catenin. Cook et al. (1996)
described that the Wingless protein of Drosophila could
inactivate the GSK-3 kinase in murine fibroblasts and sug-
gested the involvement of an upstream TPA-sensitive
PKC isoform in this process. Inactivation of GSK-3 should
lead to stabilization of b-catenin and maybe increased cell
adhesion besides signaling to the nucleus (Miller and
Moon, 1996). However, TPA-treated R-variants did not
show increased levels of b-catenin, as shown by direct
Western blotting and coimmunoprecipitation with E-cad-
herin.
The suboptimal E-cadherin comprising cell–cell adhe-
sion events of R-variants might act as indispensable orga-
nization centers for the TPA-induced establishment of ex-
tra strengthening cell junctions, i.e., desmosomes and tight
junctions, which are clearly implicated in the observed
phenomena. Indeed, the most dramatic effects of TPA
were not seen on E-cadherin–containing junctions but on
desmosome and tight junction organization (Figs. 5–7).
This was further consolidated by the antibody experi-
ments. Efficient blocking of either E-cadherin or desmo-
glein-2 was fully abrogating the TPA-induced cell aggrega-
tion. This finding excludes also that R-variants comprise
two subpopulations, which are dependent on either E-cad-
herin or desmoglein-2 for TPA-induced aggregation. It is
interesting that combination of anti–E-cadherin and anti–
desmoglein-2 antibodies at noneffective concentrations
produced a clear-cut cooperative inhibition of TPA-induced
aggregation of R-variants. A similar phenomenon was
seen for antibody-treated E-variants in the absence of
TPA. As this effect was synergistic instead of additive, it
cannot be simply explained by a threshold of adhesive
bridges, composed of either E-cadherin or desmoglein-2,
that should be reached before cell aggregation is achieved.
Except for particular conditions such as lymphatic endo-
thelial cells (Schmelz and Franke, 1993) and plakoglobin-
negative heart cells (Ruiz et al., 1996), classic studies on
cell junctions show no evidence for mixed structures, com-
posed of both E-cadherin and desmosomal proteins (ex-
cept for plakoglobin). Such peculiar junctions could have
explained the observed cooperative action of the antibod-
ies. In contrast, both confocal microscopy and EM sug-
gested that no such hybrid structures were present or in-
duced in our cell lines. It can be suggested, therefore, that
both a-catenin–lacking E-cadherin complexes and desmo-
somes are involved in mutually intercommunicating sig-
naling pathways.
The main role of a-catenin–lacking E-cadherin com-
plexes in TPA-induced cell aggregation might be the es-
tablishment of a basic though essential level of intercellu-
lar adhesion. A slightly similar situation was reported for
HeLa cells, in which exogenous adhesion protein zero (P0)
was expressed (Doyle et al., 1995). Such cells showed obvi-
ous development of desmosomes and redistribution of
tight junction proteins to apical cell contacts, as a function
of P0 expression. However, intracellular levels of des-
moplakin, N-cadherin, and even a-catenin were increased,
too, and this is in clear variance with our findings on R-vari-
ants, where a-catenin was never found to be induced. On
the other hand, aN-catenin-expressing transfectants of
R-variants showed normal intercellular cell adhesion and
also an epithelioid pattern of desmosomes, even in the ab-
sence of TPA treatment. The latter data emphasize the ap-
parently complex interplay between E-cadherin contain-
ing junctions and desmosomes.
Nevertheless, it is likely from our various observations
that the molecular target of PKC with respect to cell–cell
adhesion in the present system belongs to or influences the
desmosomal junctions, rather than the tight junctions or
E-cadherin–comprising junctions. Although tight junc-
tional proteins occludin and ZO-1 were strikingly redis-
tributed upon TPA treatment, no fully sealed tight junc-
tions were built up as evaluated by immunofluorescence
and transepithelial electrical resistance measurements.
Probably, formation of desmosomes is the driving but too
transient event to induce functional tight junctions. Re-
garding the E-cadherin complex, no obvious change in
phosphorylation of E-cadherin plus associating proteins
could be observed in TPA-treated R-variants (data not
shown). Therefore, the phosphorylation status of the
many desmosomal components, recently reviewed or newly
reported (Cowin and Burke, 1996; Mertens et al., 1996; Pin
and Sugrue, 1996), deserves further investigation. Specific
phosphorylation events may mediate the maturation of the
complicated desmosomal junction. Additional immuno-
EM studies could reveal whether the various desmosomal
components in untreated R-variants are colocalized in so-
called half-desmosomal structures (Demlehner et al., 1995).
This possibility is supported by our finding in untreated
R-variants that the bulk of desmoglein-2 molecules is in a
detergent-insoluble fraction, like in E-variants. Assembly
and disassembly of desmosomes in MDCK cells was pro-
posed to be regulated via reversible protein phosphorylation
involving both protein kinases such as PKC and protein
phophatases (Pasdar et al., 1995). However, in that cell
system phosphatases seemed to be involved in assembly
rather than disassembly.
It is widely assumed that desmosomal cadherins are in-
volved in cell–cell adhesion, but little direct evidence to
support this belief is available so far. Expression of full-
length desmocollin-1 is not sufficient to confer adhesive-
ness to transfected L929 fibroblasts (Chidgey et al., 1996).
Similarly, a chimeric protein consisting of the desmocollin-1
extracellular domain and the E-cadherin transmembrane
and cytoplasmic domains was not adhesive in the same
system, even though the chimeric protein interacted with
endogenous a- and b-catenins (Chidgey et al., 1996). A
similar chimeric molecule consisting of the desmoglein-3
extracellular domain linked to the membrane-spanning
and intracellular domains of E-cadherin is adhesive in
L929 cells, but only weakly (Amagai et al., 1994). On the
contrary, as mentioned above, the cytoplasmatic domain
of desmoglein-3 is able to confer strong adhesiveness on
the extracellular domain of E-cadherin (Roh and Stanley,
1995). Our antibody studies show that the extracellular do-
main of desmoglein-2 is indeed essential for intercellular
adhesion, at least under the conditions tested. The samevan Hengel et al. PKC Induces Desmosomes in a-Catenin–negative Cells 1115
anti–desmoglein-2 antibody was previously reported to be
nonblocking, but those studies were performed on adher-
ing instead of suspended cells (Demlehner et al., 1995). It
is interesting that defective expression of desmoglein and
desmoplakin molecules is correlated with loss of differen-
tiation and lymph node involvement in various human car-
cinomas (Nei et al., 1996; Hiraki et al., 1996). The detailed
analysis of our data is complicated by the transient nature
of PKC activation. Downregulation of PKC by sustained
TPA treatment is well established and should be consid-
ered when comparing our results with the often contradic-
tory literature on PKC activation in epithelial cells. Dis-
ruptions (Ben-Ze’ev, 1986; Citi, 1992; Dong et al., 1993;
Fabre and de Herreros, 1993; Lampe, 1994; Nilsson and
Ericson, 1995) as well as assembly of various junctional
complexes in epithelial cells (Sheu et al., 1989; Winkel et
al., 1990; Balda et al., 1993; Williams et al., 1993; De-
nisenko et al., 1994; Lewis et al., 1995; Stuart and Nigam,
1995) have been described to result from PKC activation.
Downregulation of PKC has been forwarded as a fair ex-
planation for transient effects on cell junction functional-
ity (Sheu et al., 1989; Winkel et al., 1990; Lewis et al.,
1995), and also we observed reversibility upon prolonged
TPA treatment. Despite this complexity, it might be clear
from our findings that remarkably genuine cell junctions
can be formed in the absence of the important bridge mol-
ecule a-catenin. The key role of PKC in either the basic as-
sembly or the strengthening of various epithelial cell junc-
tions is emphasized and so is the functional interplay
between E-cadherin and desmosomal cadherins. Further
studies on R-variants may allow identification of the rele-
vant PKC substrate. Such a protein may play a key role in
cell–cell adhesion.
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